Solutions for Constipation Relief
The Thyroid Pharmacist
SEPTEMBER 20, 2024
Tegaserod : This medication was approved for IBS-C in 2002, but removed from the market in 2007 due to an increased risk of cardiovascular events. Alterations in the colonic flora and intestinal permeability and evidence of immune activation in chronic constipation. Accessed June 6, 2023. Dig Liver Dis. 2005;37(11):838-849. 2016;7:414.
Let's personalize your content